Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Betta Pharmaceuticals Co Ltd (300558)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
40.54 +1.43    +3.66%
26/04 - Closed. Currency in CNY ( Disclaimer )
  • Volume: 9,261,901
  • Bid/Ask: 40.54 / 40.54
  • Day's Range: 38.72 - 40.72
Type:  Equity
Market:  China
ISIN:  CNE100002DD9 
Betta Pharma 40.54 +1.43 +3.66%

Betta Pharma Company Profile

 
Read the Betta Pharmaceuticals Co Ltd company profile to learn more about the business and the management team. View Betta Pharmaceuticals Co Ltd facts about employee data, company products and services, and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

1961

Equity Type

ORD

Betta Pharmaceuticals Co., Ltd. researches and develops, manufactures, and markets medicines for the treatment of cancer in China. The company offers Icotinib hydrochloride, an oral epidermal growth factor receptor tyrosine kinase inhibitor, which is used to treat non-small-cell lung cancer; and Ensartinib hydrochloride, an anaplastic lymphoma kinase inhibitor for the treatment of non-small cell lung cancer. The company was founded in 2003 and is headquartered in Hangzhou, China.

Contact Information

Address No. 355, Xingzhong Road Yuhang Eco & Tech Dev Zn
Hangzhou, 311100
China
Phone 86 57 1892 65665
Fax 86 57 1892 65665

Top Executives

Name Age Since Title
Xinqi Huang 52 2021 Independent Director
Lieming Ding 61 2013 Founder, Chairman of the Board of Directors, CEO & GM
Jiang Wan 56 2019 Senior VP, COO & Director
Jianxun Fan 53 2017 VP, CFO & Director
Jiabing Wang 61 2019 Senior VP, Chief Scientific Officer & Director
Zhihua Yu 57 2019 Director
Jia Tong 47 - Director
Wei Wang 57 2019 Independent Director
Cai Jiangnan 67 2019 Independent Director
Tian Xu 62 2022 Director
Rong Wang 61 2022 Shareholder Supervisor
Yangnan Zhang 53 2019 Chairman of the Supervisory Board & Senior Director of Project Declaration
Fei Wu 47 - Supervisor
Jiajia Xiao 41 2022 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

300558 Price Commentary

Write your thoughts about Betta Pharmaceuticals Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email